Activation of Stat1, IRF-1, and NF-κB is Required for the Induction of Uridine Phosphorylase by Tumor Necrosis Factor-α and Interferon-γ

REFERENCES

• Pizzorno , G. , Diasio , R. B. Cheng , Y.-C. “ Pyrimidine and purine antimetabolites ” . In Cancer Medicine Edited by: Bast , R. C. and Decker , B. C. London, 2000, pp. 625–647
   Google Scholar
• Armstrong , R. D. and Diasio , R. B. 1980 . Metabolism and biological activity of 5′-deoxy-5-fluorouridine, a novel fluoropyrimidine . Cancer Res. , 40 : 3333 – 3338 .
   PubMed Web of Science ®Google Scholar
• Patterson , A. V. , Zhang , H. , Moghaddam , A. , Bicknell , R. , Talbot , D. C. , Stratford , I. J. and Harris , A. L. 1995 . Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase . Br. J. Cancer , 2 : 669 – 675 .
   Google Scholar
• Reigner , B. , Blesch , K. and Weidekamm , E. 2001 . Clinical pharmacokinetics of capecitabine . Clin. Pharmacokinet. , 40 : 85 – 104 .
   PubMed Web of Science ®Google Scholar
• Ishikawa , T. , Utoh , M. , Sawada , N. , Nishida , M. , Fukase , Y. , Sekiguchi , F. and Ishitsuka , H. 1998 . Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts . Biochem. Pharmacol. , 55 : 1091 – 1097 .
   PubMed Web of Science ®Google Scholar
• Schuller , J. , Cassidy , J. , Dumont , E. , Roos , B. , Durston , S. , Banken , L. , Utoh , M. , Mori , K. , Weidekamm , E. and Reigner , B. 2000 . Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients . Cancer Chemother. Pharmacol. , 45 : 291 – 297 .
   PubMed Web of Science ®Google Scholar
• Cao , D. , Russell , R. L. , Zhang , D. , Leffert , J. J. and Pizzorno , G. 2002 . Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines . Cancer Res. , 62 : 2313 – 2317 .
   PubMed Web of Science ®Google Scholar
• Schwartz , P. M. , Moir , R. D. , Hyde , C. M. , Turek , P. J. and Handschumacher , R. E. 1985 . Role of uridine phosphorylase in the anabolism of 5-fluorouracil . Biochem. Pharmacol. , 34 : 3585 – 3589 .
   PubMed Web of Science ®Google Scholar
• Pizzorno , G. , Cao , D. , Leffert , J. J. , Russell , R. L. , Zhang , D. and Handschumacher , R. E. 2002 . Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update . Biochim. Biophys. Acta , 1587 : 133 – 144 .
   PubMed Web of Science ®Google Scholar
• Wan , L. , Cao , D. , Zeng , J. , Yan , R. and Pizzorno , G. 2006 . Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5′-deoxy-5-fluorouridine in breast cancer cells . Mol. Pharmacol. , 69 : 1389 – 1395 .
   PubMed Web of Science ®Google Scholar
• de Bruin , M. , van Capel , T. , Van der Born , K. , Kruyt , F. A. , Fukushima , M. , Hoekman , K. , Pinedo , H. M. and Peters , G. J. 2003 . Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity . Br. J. Cancer , 88 : 957 – 964 .
   PubMed Web of Science ®Google Scholar
• Merika , M. , Williams , A. J. , Chen , G. , Collins , T. and Thanos , D. 1998 . Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription . Mol. Cell , 1 : 277 – 287 .
   PubMed Web of Science ®Google Scholar
• Eda , H. , Fujimoto , K. , Watanabe , S. , Ishikawa , T. , Ohiwa , T. , Tatsuno , K. , Tanaka , Y. and Ishitsuka , H. 1993 . Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5′-deoxy-5-fluorouridine . Jpn. J. Cancer Res. , 84 : 341 – 347 .
   PubMedGoogle Scholar
• Eda , H. , Fujimoto , K. , Watanabe , S. , Ura , M. , Hino , A. , Tanaka , Y. , Wada , K. and Ishitsuka , H. 1993 . Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine . Cancer Chemother. Pharmacol. , 32 : 333 – 338 .
   PubMed Web of Science ®Google Scholar
• Haraguchi , M. , Miyadera , K. , Uemura , K. , Sumizawa , T. , Furukawa , T. , Yamada , K. , Akiyama , S. and Yamada , Y. 1994 . Angiogenic activity of enzymes . Nature , 368 : 198
   PubMed Web of Science ®Google Scholar
• Toi , M. , Inada , K. , Hoshina , S. , Suzuki , H. , Kondo , S. and Tominaga , T. 1995 . Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer . Clin. Cancer Res. , 1 : 961 – 964 .
   PubMed Web of Science ®Google Scholar
• Tanigawa , N. , Amaya , H. , Matsumura , M. , Katoh , Y. , Kitaoka , A. , Aotake , T. , Shimomatsuya , T. , Rosenwasser , O. A. and Iki , M. 1996 . Tumor angiogenesis and expression of thymidine phosphorylase/platelet derived endothelial cell growth factor in human gastric carcinoma . Cancer Lett. , 108 : 281 – 290 .
   PubMed Web of Science ®Google Scholar
• Kimura , H. , Konishi , K. , Nukui , T. , Kaji , M. , Maeda , K. , Yabushita , K. , Tsuji , M. and Miwa , A. 2001 . Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma . J. Surg. Oncol. , 76 : 31 – 36 .
   PubMed Web of Science ®Google Scholar
• Toi , M. , Ueno , T. , Matsumoto , H. , Saji , H. , Funata , N. , Koike , M. and Tominaga , T. 1999 . Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer . Clin. Cancer Res. , 5 : 1131 – 1137 .
   PubMed Web of Science ®Google Scholar
• Makower , D. , Wadler , S. , Haynes , H. and Schwartz , E. L. 1997 . Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo . Clin. Cancer Res. , 3 : 923 – 929 .
   PubMed Web of Science ®Google Scholar
• Schwartz , E. L. , Wan , E. , Wang , F.-S. and Baptiste , N. 1998 . Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells . Cancer Res. , 58 : 1551 – 1557 .
   PubMed Web of Science ®Google Scholar
• Liu , M.-P. , Cao , D.-L. , Russell , R. L. , Handschumacher , R. E. and Pizzorno , G. 1998 . Expression, characterization and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumor . Cancer Res. , 58 : 5418 – 5424 .
   PubMed Web of Science ®Google Scholar
• Zhang , D. , Cao , D. , Russell , R. and Pizzorno , G. 2001 . p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction . Cancer Res. , 61 : 6899 – 6905 .
   PubMed Web of Science ®Google Scholar
• Cheshire , J. L. and Baldwin , A. S. Jr. 1997 . Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation . Mol. Cell Biol. , 17 : 6746 – 6754 .
   PubMed Web of Science ®Google Scholar
• Thanos , D. and Maniatis , T. 1995 . NF-kappa B: a lesson in family values . Cell , 80 : 529 – 532 .
   PubMed Web of Science ®Google Scholar
• Shuai , K. , Schindler , C. , Prezioso , V. R. and Darnell , J. E. Jr. 1992 . Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein . Science , 258 : 1808 – 1812 .
   PubMed Web of Science ®Google Scholar
• Woods , M. , Wood , E. G. , Bardswell , S. C. , Bishop-Bailey , D. , Barker , S. , Wort , S. J. , Mitchell , J. A. and Warner , T. D. 2003 . Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells . Mol. Pharmacol. , 64 : 923 – 931 .
   PubMed Web of Science ®Google Scholar
• Paludan , S. R. 2000 . Synergistic action of pro-inflammatory agents: cellular and molecular aspects . J. Leukoc. Biol. , 67 : 18 – 25 .
   PubMed Web of Science ®Google Scholar
• Drew , P. D. , Franzoso , G. , Becker , K. G. , Bours , V. , Carlson , L. M. , Siebenlist , U. and Ozato , K. 1995 . NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression . J. Interferon Cytokine Res. , 15 : 1037 – 1045 .
   PubMed Web of Science ®Google Scholar
• Deb , A. , Haque , S. J. , Mogensen , T. , Silverman , R. H. and Williams , B. R. 2001 . RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway . J. Immunol. , 166 : 6170 – 6180 .
   PubMed Web of Science ®Google Scholar
• Goto , H. , Kohno , K. , Sone , S. , Akiyama , S. , Kuwano , M. and Ono , M. 2001 . Interferon gamma-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through gamma-activated sequence-like element in human macrophages . Cancer Res. , 61 : 469 – 473 .
   PubMed Web of Science ®Google Scholar
• Yao , Y. , Kubota , T. , Sato , K. , Takeuchi , H. , Kitai , R. and Matsukawa , S. 2005 . Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells . J. NeuroOncol. , 72 : 217 – 223 .
   PubMed Web of Science ®Google Scholar
• Zhu , G. H. , Lenzi , M. and Schwartz , E. L. 2002 . The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells . Oncogene , 21 : 8477 – 8485 .
   PubMed Web of Science ®Google Scholar
• Chen , L.-C. , Liu , H.-P. , Li , H.-P. , Hsueh , C. , Yu , J.-S. , Liang , C.-L. and Chang , Y.-S. 2009 . Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells . Oncogene , 28 : 1904 – 1915 .
   PubMed Web of Science ®Google Scholar
• Schwartzberg , L. S. , Petak , I. , Stewart , C. , Turner , P. K. , Ashley , J. , Tillman , D. M. , Douglas , L. , Tan , M. , Billups , C. , Mihalik , R. , Weir , A. , Tauer , K. , Shope , S. and Houghton , J. A. 2002 . Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin . Clin. Cancer Res. , 8 : 2488 – 2498 .
   PubMed Web of Science ®Google Scholar
• Sparano , J. A. , Wadler , S. , Liebes , L. , Robert , N. J. , Schwartz , E. L. and Dutcher , J. P. 1993 . Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancer . Cancer Res. , 53 : 3509 – 3512 .
   PubMed Web of Science ®Google Scholar
• Tillman , D. M. , Petak , I. and Houghton , J. A. 1999 . A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells . Clin. Cancer Res. , 5 : 425 – 430 .
   PubMed Web of Science ®Google Scholar
• Walters , R. S. , Theriault , R. L. , Booser , D. J. , Esparza , L. and Hortobagyi , G. N. 1995 . Phase II study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer . J. Immunother. Emphasis Tumor Immunol. , 18 : 185 – 187 .
   PubMed Web of Science ®Google Scholar
• Kurosumi , M. , Tabei , T. Suemasu , K. 2000 . Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients . Oncol. Rep. , 7 : 945 – 948 .
   PubMed Web of Science ®Google Scholar
• Endo , M. , Shinbori , N. , Fukase , Y. , Sawada , N. , Ishikawa , T. , Ishitsuka , H. and Tanaka , Y. 1999 . Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5′-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models . Int. J. Cancer , 83 : 127 – 134 .
   PubMed Web of Science ®Google Scholar
• Sawada , N. , Ishikawa , T. , Sekiguchi , F. , Tanaka , Y. and Ishitsuka , H. 1999 . X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts . Clin. Cancer Res. , 5 : 2948 – 2953 .
   PubMed Web of Science ®Google Scholar